266 related articles for article (PubMed ID: 15626276)
21. Fetal atrial flutter: a case report and experience of sotalol treatment.
Wu TH; Huang LC; Ho M; Lee CC; Chiu TH; Hung YC
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):79-82. PubMed ID: 17272217
[TBL] [Abstract][Full Text] [Related]
22. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
Parilla BV; Strasburger JF; Socol ML
Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
[TBL] [Abstract][Full Text] [Related]
23. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia.
Holmes S; Hornberger LK; Jaeggi E; Howley L; Moon-Grady AJ; Uzun O; Kaizer A; Gilicze O; Cuneo BF
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):552-557. PubMed ID: 37128167
[TBL] [Abstract][Full Text] [Related]
24. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia.
Jouannic JM; Le Bidois J; Fermont L; Villain E; Mahieu-Caputo D; Dumez Y; Dommergues M
Fetal Diagn Ther; 2002; 17(2):120-3. PubMed ID: 11844918
[TBL] [Abstract][Full Text] [Related]
25. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M
J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376
[TBL] [Abstract][Full Text] [Related]
26. [Protocols for the treatment of supraventricular tachycardias in the fetus].
Oudijk MA; Ambachtsheer EB; Stoutenbeek P; Meijboom EJ
Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1218-9. PubMed ID: 11447879
[TBL] [Abstract][Full Text] [Related]
27. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
[TBL] [Abstract][Full Text] [Related]
28. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?
Jouannic JM; Delahaye S; Fermont L; Le Bidois J; Villain E; Dumez Y; Dommergues M
Prenat Diagn; 2003 Feb; 23(2):152-6. PubMed ID: 12575024
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK
Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730
[TBL] [Abstract][Full Text] [Related]
30. Foetal supraventricular tachycardia treated with sotalol.
Sonesson SE; Fouron JC; Wesslen-Eriksson E; Jaeggi E; Winberg P
Acta Paediatr; 1998 May; 87(5):584-7. PubMed ID: 9641744
[TBL] [Abstract][Full Text] [Related]
31. [Transplacental cardioversion of fetal supraventricular tachycardia using sotalol].
Meden H; Neeb U
Z Geburtshilfe Perinatol; 1990; 194(4):182-4. PubMed ID: 2396467
[TBL] [Abstract][Full Text] [Related]
32. Successful digoxin therapy of fetal supraventricular tachycardia in a triplet pregnancy.
Jones LM; Garmel SH
Obstet Gynecol; 2001 Nov; 98(5 Pt 2):921-3. PubMed ID: 11704204
[TBL] [Abstract][Full Text] [Related]
33. Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis.
Hill GD; Kovach JR; Saudek DE; Singh AK; Wehrheim K; Frommelt MA
Prenat Diagn; 2017 Nov; 37(11):1076-1083. PubMed ID: 28833310
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine therapy for fetal supraventricular tachycardia in a twin pregnancy.
Tanawattanacharoen S; Uerpairojkit B; Prechawat S; Manotaya S; Charoenvidhya D
J Obstet Gynaecol Res; 2005 Apr; 31(2):94-7. PubMed ID: 15771633
[TBL] [Abstract][Full Text] [Related]
35. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings.
Fouron JC; Fournier A; Proulx F; Lamarche J; Bigras JL; Boutin C; Brassard M; Gamache S
Heart; 2003 Oct; 89(10):1211-6. PubMed ID: 12975422
[TBL] [Abstract][Full Text] [Related]
36. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
[No Abstract] [Full Text] [Related]
37. Resolution of Fetal Hydrops Dependent on Sustained Fetal Supraventricular Tachycardia after Digoxin Therapy.
Maciuleviciute A; Semenaite M; Gintautas V; Maciuleviciene R; Puodziukynas A; Savukyne E
Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32392830
[TBL] [Abstract][Full Text] [Related]
38. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia.
Strizek B; Berg C; Gottschalk I; Herberg U; Geipel A; Gembruch U
Heart Rhythm; 2016 Jun; 13(6):1283-8. PubMed ID: 26829115
[TBL] [Abstract][Full Text] [Related]
39. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
Campbell JQ; Best TH; Eswaran H; Lowery CL
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
[TBL] [Abstract][Full Text] [Related]
40. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
